A Mass Balance Study of [14C]ABSK021

Clinical trial NCT06186583 · COMPLETED

Trial details

NCT number: NCT06186583
Sponsor: Abbisko Therapeutics Co, Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2023-12-13
Primary completion: 2024-05-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.